NOT-DA-13-015: Notice of NIDA's Participation in RFA-NS-13-013 Collaborative Research on Chronic Traumatic Encephalopathy and Delayed Effects of Traumatic Brain Injury: Neuropathology and Neuroimaging Correlation (U01)

Notice of NIDA's Participation in RFA-NS-13-013 "Collaborative Research on Chronic Traumatic Encephalopathy and Delayed Effects of Traumatic Brain Injury: Neuropathology and Neuroimaging Correlation (U01)"

Notice Number: NOT-DA-13-015

Key Dates

Release Date: March 21, 2013

Related Announcements

RFA-NS-13-013

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants of the National Institute on Drug Abuse (NIDA)'s intent to participate, effective immediately, in the Funding Opportunity Announcement (FOA) RFA-NS-13-013, entitled "Collaborative Research on Chronic Traumatic Encephalopathy and Delayed Effects of Traumatic Brain Injury: Neuropathology and Neuroimaging Correlation (U01)."

RFA-NS-13-013 has been changed in the following ways to indicate NIDA's participation in this FOA.

Part 1. Overview Information

Components of Participating Organizations

National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Drug Abuse (NIDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.859, 93.213, 93.279

Part 2. Section I. Funding Opportunity Description

Specific Areas of Research Interest

For this FOA, specific topics of interest to NIDA include:

Interactive effects of prescribed analgesic or stimulant medication on morphological or histological brain signatures of TBI.

Interactive effects of comorbid substance use or abuse (including nicotine) histories on morphological or histological brain signatures of TBI.

Part 2. Section II. Award Information

Funds Available and Anticipated Number of Awards

NIDA support for this FOA is contingent on the availability of funds and the receipt of meritorious applications.

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

James Bjork, Ph.D.
Clinical Neuroscience Branch
Division of Clinical Neuroscience and Behavioral Research
National Institute on Drug Abuse (NIDA)
Phone: 301-443-3209
Email: [email protected]

Financial/Grants Management Contact(s)

Maryellen Connell
Grants Management Branch
National Institute on Drug Abuse (NIDA)
Phone: 301-774-3803
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

James Bjork, Ph.D.
Clinical Neuroscience Branch
Division of Clinical Neuroscience and Behavioral Research
National Institute on Drug Abuse (NIDA)
Phone: 301-443-3209
Email: [email protected]